Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.32 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 4/20 | 0.32 |
| ▸ | TP53 | P04637 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28686868 | 0.78 | GRM4 (0.35) | LMNAIDH1ALOX5APFEN1DYRK1B | |
| SCHEMBL4138614 | 0.78 | NPSR1 (0.42) | PARP1LMNASMN1; SMN2HTTTP53 | |
| SCHEMBL30637352 | 0.78 | NPSR1 (0.42) | PARP1LMNASMN1; SMN2HTTTP53 | |
| SCHEMBL3599059 | 0.78 | LOX (0.35) | LMNAIDH1ALOX5APFEN1HTT | |
| SCHEMBL2018052 | 0.77 | IDH1 (0.38) | LMNAIDH1POLBLOXKDM4E | |
| SCHEMBL22471636 | 0.77 | PARP1 (0.37) | PARP1LMNASMN1; SMN2DYRK1ADYRK2 | |
| SCHEMBL13074743 | 0.77 | PARP1 (0.37) | PARP1LMNASMN1; SMN2DYRK1ADYRK2 | |
| SCHEMBL20606050 | 0.77 | LMNA (0.39) | PARP1LMNASMN1; SMN2DYRK1ADYRK2 | |
| SCHEMBL3929459 | 0.77 | PARP1 (0.37) | PARP1LMNASMN1; SMN2DYRK1ADYRK2 | |
| SCHEMBL1490042 | 0.77 | MTOR (0.37) | PARP1LMNASMN1; SMN2ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-209326137-U | Cooling device is used in 4,6- of one kind dimethoxy-dimesyl pyrimidine preparation | 江西聚合医药科技有限公司 | 2019-08-30 | — | — | CN | claimed |
| US-7968553-B2 | e.g. N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxamide; viricide in combination with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; AIDS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2011-06-28 | — | — | US | disclosed |
| EP-1578748-B1 | TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDINES AND RELATED COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS | ANGELETTI P IST RICHERCHE BIO (IT) | 2010-09-15 | — | — | EP | disclosed |
| US-7414045-B2 | Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2008-08-19 | — | — | US | disclosed |
| US-7405221-B2 | Substituted pyrimidines | MERCK & CO., INC. (US) | 2008-07-29 | — | — | US | disclosed |
| US-20080176869-A1 | Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors | MSD ITALIA S.R.L. (IT) | 2008-07-24 | — | — | US | disclosed |
| US-7291645-B2 | Phenylalanine derivatives as alpha 4 integrin inhibitors | ELAN PHARMACEUTICALS, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| EP-1694678-A2 | PROCESS FOR PREPARING HEXAHYDROPYRIMIDO 1,2-A¨AZEPINE-2-CARBOXYLATES AND RELATED COMPOUNDS | Merck & Co., Inc. (US) | 2006-08-30 | — | — | EP | disclosed |
| US-7015216-B2 | Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors | ELAN PHARMACEUTICALS, INC. (US) | 2006-03-21 | — | — | US | disclosed |
| US-20060046985-A1 | Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors | MSD ITALIA S.R.L. (IT) | 2006-03-02 | — | — | US | disclosed |
| US-5270454-A | Reactive dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1993-12-14 | — | — | US | disclosed |
| US-5023326-A | Monoazo, naphthol, aniline and triazine red dyes; colorfastness; cotton | CIBA-GEIGY CORPORATION (US) | 1991-06-11 | — | — | US | disclosed |
| US-4917705-A | Process for dyeing or printing of fibre material from natural or synthetic polyamides with reactive disazo dyes | CIBA-GEIGY CORP. (US) | 1990-04-17 | — | — | US | disclosed |
| US-4877413-A | Process for the end-to-end dyeing of cellulosic fibres | CIBA-GEIGY CORPORATION (US) | 1989-10-31 | — | — | US | disclosed |
| US-4828572-A | MONOAZO DYES | CIBA-GEIGY CORPORATION (US) | 1989-05-09 | — | — | US | disclosed |
| US-4693727-A | Process for dyeing synthetic polyamide materials with fibre-reactive anthraquinone dyes | CIBA-GEIGY CORPORATION (US) | 1987-09-15 | — | — | US | disclosed |
| US-4659333-A | Process for fixing dyes and prints with hot steam containing air | CIBA-GEIGY CORPORATION (US) | 1987-04-21 | — | — | US | disclosed |
| US-4652269-A | Process for the continuous trichromatic dyeing of synthetic polyamide materials: including a blue anthraquinone reactive dye | CIBA-GEIGY CORPORATION (US) | 1987-03-24 | — | — | US | disclosed |
| US-4647285-A | Process for printing cellulosic fibres with reactive dye and C3-18 aliphatic carboxylate salt fixing agent | CIBA-GEIGY CORPORATION (US) | 1987-03-03 | — | — | US | disclosed |
| US-4588411-A | Long-shelflife print containing reactive dye and alkali acetate pastes and their use | CIBA-GEIGY CORPORATION (US) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060046985-A1 | Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors | TYMS, TYMP, HPRT1 | PARP1 250/4885LMNA 3967/4885SMN1; SMN2 2355/4885 |
| US-20080176869-A1 | Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors | TYMS, TYMP, DPYD | PARP1 257/4885LMNA 4114/4885SMN1; SMN2 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.